Aventis Pushes For Novartis Merger: Evokes European Pride In French Talks
Executive Summary
Aventis believes a merger with Novartis would be more beneficial to Europe's pharmaceutical industry than a deal with Sanofi, the company said April 5
You may also be interested in...
Novartis And Aventis Begin Merger Talks; Sanofi Considers Raising Bid
Sanofi will continue to evaluate the market response to its tender offer for Aventis before deciding whether to sweeten its bid, CFO Marie-Helene Laimay said during a first quarter investor call April 22
Novartis And Aventis Begin Merger Talks; Sanofi Considers Raising Bid
Sanofi will continue to evaluate the market response to its tender offer for Aventis before deciding whether to sweeten its bid, CFO Marie-Helene Laimay said during a first quarter investor call April 22
Rx Stocks Suffer Medicare Hangover; Aventis Bid Fails To Spark Rally
Aventis is winning the battle to persuade investors that it is worth more than Sanofi says, but the budding bidding war for the company has not been enough to cure Wall Street's aversion to pharmaceutical stocks